Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
sores on body; sores that itch; This non-serious case was reported by a consumer via call center representative and described the occurrence of skin ulcer in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 week after receiving Shingrix, the patient experienced skin ulcer (Verbatim: sores on body) and pruritus (Verbatim: sores that itch). The outcome of the skin ulcer and pruritus were not resolved. It was unknown if the reporter considered the skin ulcer and pruritus to be related to Shingrix. It was unknown if the company considered the skin ulcer and pruritus to be related to Shingrix. Additional Information: GSK Receipt Date: 23-APR-2025 The case was self reported by patient. She was vaccinated with her first dose of Shingrix a few weeks back and about a week after vaccination she has sores on her body and the sores are itchy. The sores are located on her legs and her back near her neck. The consumer declined to provide any demographic information or information pertaining to vaccination. No further information was provided/obtained.